Fu Xuan, Chen Ti, Cai Jingda, Liu Bo, Zeng Yaohui, Zhang Xiaojie
Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China.
National Clinical Research Center on Mental Disorders, Changsha, China.
Front Microbiol. 2021 Oct 6;12:738401. doi: 10.3389/fmicb.2021.738401. eCollection 2021.
Substance addiction is a complex worldwide public health problem. It endangers both personal life and social stability, causing great loss on economy. Substance-related disorder is considered to be a complicated chronic brain disorder. It resulted from interactions among pharmacological properties of addictive substances, individual susceptibility, and social-environmental factors. Unfortunately, there is still no ideal treatment for this disorder. Recent lines of evidence suggest that gut microbiome may play an important role in the pathogenesis of neuropsychiatric disorders, including substance-related disorders. This review summarizes the research on the relationship between gut microbiome and substance-related disorders, including different types of substance, different individual susceptibility, and the occurrence and development of substance-induced mental disorders. We also discuss the potentiation of gut microbiome in the treatment of substance-related disorders, especially in the treatment of substance-induced mental disorders and manipulation on individuals' responsiveness to addictive substances.
物质成瘾是一个复杂的全球性公共卫生问题。它危及个人生活和社会稳定,造成巨大的经济损失。物质相关障碍被认为是一种复杂的慢性脑部疾病。它是由成瘾物质的药理特性、个体易感性和社会环境因素之间的相互作用导致的。不幸的是,目前仍没有针对这种疾病的理想治疗方法。最近的一系列证据表明,肠道微生物群可能在神经精神疾病(包括物质相关障碍)的发病机制中发挥重要作用。这篇综述总结了关于肠道微生物群与物质相关障碍之间关系的研究,包括不同类型的物质、不同的个体易感性以及物质所致精神障碍的发生和发展。我们还讨论了肠道微生物群在物质相关障碍治疗中的增强作用,特别是在物质所致精神障碍的治疗以及对个体对成瘾物质反应性的调节方面。